Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Willie Earley, MD
Allergan
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
72 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Forest Investigative Site 201
Tallinn, Estonia
- Forest Investigative Site 203
Tallinn, Estonia
- Forest Investigative Site 205
Tallinn, Estonia
- Forest Investigative Site 206
Tallinn, Estonia
- Forest Investigative Site 204
Tartu, Estonia
- Forest Investigative Site 207
Tartu, Estonia
- Forest Investigative Site 208
Tartu, Estonia
- Forest Investigative Site 202
Võru, Estonia
- Forest Investigative Site 301
Helsinki, Finland
- Forest Investigative Site 302
Helsinki, Finland
- Forest Investigative Site 303
Helsinki, Finland
- Forest Investigative Site 304
Helsinki, Finland
- Forest Investigative Site 305
Kuopio, Finland
- Forest Investigative Site 308
Oulu, Finland
- Forest Investigative Site 307
Pori, Finland
- Forest Investigative Site 602
Banská Štiavnica, Slovakia
- Forest Investigative Site 603
Bardejov, Slovakia
- Forest Investigative Site 604
Bratislava, Slovakia
- Forest Investigative Site 606
Bratislava, Slovakia
- Forest Investigative Site 601
Michalovce, Slovakia
- Forest Investigative Site 605
Rimavská Sobota, Slovakia
- Forest Investigative Site 607
Rimavská Sobota, Slovakia
- Forest Investigative Site 803
Lund, Sweden
- Forest Investigative Site 802
Malmö, Sweden
- Forest Investigative Site 801
Stockholm, Sweden
- Forest Investigative Site 705
Stepanivka, Kherson Oblast, Ukraine
- Forest Investigative Site 703
Kharkiv, Ukraine
- Forest Investigative Site 704
Kharkiv, Ukraine
- Forest Investigative Site 701
Kyiv, Ukraine
- Forest Investigative Site 702
Kyiv, Ukraine
- Forest Investigative Site 710
Luhansk, Ukraine
- Forest Investigative Site 709
Odesa, Ukraine
- Forest Investigative Site 706
Vinnytsia, Ukraine
- Forest Investigative Site 077
Garden Grove, California, United States
- Forest Investigative Site 019
National City, California, United States
- Forest Investigative Site 039
Oceanside, California, United States
- Forest Investigative Site 015
Orange, California, United States
- Forest Investigative Site 050
Orange, California, United States
- Forest Investigative Site 008
Redlands, California, United States
- Forest Investigative Site 066
Sherman Oaks, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Dec 2011
- Primary completion
- 12 Dec 2013
- Completion
- 12 Dec 2013
- Last update posted
- 1 May 2018
- Registered enrollment
- 819
- Registry id
- NCT01469377
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.